Skip to main content
Công ty Cổ phần Dược phẩm Imexpharm logo

Công ty Cổ phần Dược phẩm Imexpharm — Investor Relations & Filings

Ticker · IMP ISIN · VN000000IMP0 HSX Manufacturing
Open in API
Filings indexed 381 across all filing types
Latest filing 2024-10-01 Governance Information
Country VN Viet Nam
Listing HSX IMP

About Công ty Cổ phần Dược phẩm Imexpharm

www.imexpharm.com

Imexpharm Corporation is a prominent pharmaceutical company with over 48 years of experience in the manufacturing, compounding, and distribution of high-quality pharmaceutical products. The company operates extensive production facilities, including three EU-GMP certified factory clusters and one WHO-GMP certified cluster, making it a leader in EU-GMP compliant manufacturing. Imexpharm is recognized as a top producer of antibiotics and offers a diverse product portfolio encompassing injectable and oral antibiotics, cardiovascular, ophthalmic, musculoskeletal, respiratory, and digestive system treatments, alongside vitamins, minerals, and health protection foods. With 28 product registrations for 11 products in Europe, Imexpharm is dedicated to delivering effective and safe healthcare solutions to the community.

Recent filings

Filing Released Lang Actions
IMP: Điều lệ công ty
Governance Information Classification · 82% confidence The document is a regulatory disclosure announcing the issuance of an amended company Charter (Điều lệ) following a capital increase, and it then provides the full text of the corporate Charter (definition of terms, governance structure, shareholder meeting rules, board composition, audit, etc.). This is clearly the company’s internal governance rules and structure. Therefore it falls under Governance Information (CGR).
2024-10-01 Vietnamese
IMP: Thông báo công văn của UBCKNN về việc nhận được tài liệu báo cáo kết quả phát hành cổ phiếu để tăng vốn cổ phần từ NVCSH của IMP
Share Issue/Capital Change Classification · 92% confidence The document is a disclosure to the State Securities Commission and Ho Chi Minh Stock Exchange reporting the results of Imexpharm’s issuance of 77,004,481 new shares to increase charter capital from owners’ equity. It contains no detailed financial statements but is clearly an announcement of a share issuance/capital change. This aligns with the “Share Issue/Capital Change” category (SHA).
2024-10-01 Vietnamese
IMP: Thông báo ngày ĐKCC lấy ý kiến cổ đông bằng văn bản
Declaration of Voting Results & Voting Rights Announcements Classification · 87% confidence The document is a formal notice (“Thông Báo”) filed with the Vietnam Securities Depository Centre announcing the record date and mechanics for shareholders to exercise their voting rights by written consent. It does not contain financial statements, management changes, dividends, or M&A details, nor is it a mere publication announcement. It is specifically a voting rights announcement (“Voting Rights Announcements”), fitting the Declaration of Voting Results & Voting Rights Announcements category.
2024-09-30 Vietnamese
IMP: Nghị quyết HĐQT về việc lấy ý kiến cổ đông bằng văn bản
Board/Management Information Classification · 75% confidence The document is a formal disclosure of a Board of Directors resolution filed with the securities regulator and stock exchange, which includes board member resignation and election, as well as other governance decisions. It is not a full financial report or earnings release, nor a proxy statement to solicit voting materials for a shareholder meeting per se. Instead, it announces board-level decisions (resignation and appointment of directors) and is therefore best classified as Board/Management Information.
2024-09-30 Vietnamese
IMP: Nghị quyết HĐQT về việc thanh lý tài sản
Regulatory Filings Classification · 88% confidence The document is an official disclosure by Imexpharm on the State Securities Commission’s and HoSE’s portals about a Board of Directors’ resolution to liquidate certain assets (investment shares and real estate). It contains no financial statements, no changes in management or board members, no earnings or other specialized content. It is a regulatory announcement that does not fit into any of the specific categories (e.g., not an earnings release, not a merger filing, not a dividend notice). According to the fallback rules, this is a general regulatory announcement (miscellaneous filing).
2024-09-30 Vietnamese
IMP: Thông báo nhận được đơn từ nhiệm của Người nội bộ
Board/Management Information Classification · 95% confidence The document is an official disclosure announcing that a member of the Board of Directors (Ms. Chun Chaerhan) has submitted her resignation and will be formally approved at the next General Meeting of Shareholders. There is no financial data or broader report attached, nor is this about share transactions or dividends. It is specifically a change in the company’s board composition, matching the definition for Board/Management Information (Code: MANG).
2024-09-27 Vietnamese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.